PubMed

On the way to specifically targeting minimal residual disease?

Gebauer G.

Breast Cancer Res. 2008;10(5):112. Epub 2008 Oct 7.PMID: 18947365 [PubMed - indexed for MEDLINE]Related articlesFree article

ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients.

Fehm T, Krawczyk N, Solomayer EF, Becker-Pergola G, Dürr-Störzer S, Neubauer H, Seeger H, Staebler A, Wallwiener D, Becker S.

Breast Cancer Res. 2008;10(5):R76. Epub 2008 Sep 15.PMID: 18793387 [PubMed - indexed for MEDLINE]Related articlesFree article

Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells.

Fehm T, Hoffmann O, Aktas B, Becker S, Solomayer EF, Wallwiener D, Kimmig R, Kasimir-Bauer S.

Breast Cancer Res. 2009;11(4):R59. Epub 2009 Aug 10.PMID: 19664291 [PubMed - indexed for MEDLINE]Related articlesFree article

[Current status of treatment for early-stage invasive breast cancer]

Kásler M, Polgár C, Fodor J.

Orv Hetil. 2009 May 31;150(22):1013-21. Hungarian. PMID: 19465349 [PubMed - indexed for MEDLINE]Related articles

[Breast cancer adjuvants: results of a DUR (drug utilization research) study]

Nuzzo A.

Suppl Tumori. 2004 Jul-Aug;3(4):S86-7. Italian. No abstract available. PMID: 15206223 [PubMed - indexed for MEDLINE]Related articles

[Early-stage breast cancer - strategies for adjuvant systemic therapy]

Görner M, Just M, Gerull S.

Handchir Mikrochir Plast Chir. 2008 Aug;40(4):230-8. Epub 2008 Aug 20. Review. German. PMID: 18716990 [PubMed - indexed for MEDLINE]Related articles

[Intensification of a diffuse chronic pain syndrome by the introduction of an aromatase inhibitor]

Nemitz N, Kurmann PT, Van Linthoudt D.

Praxis (Bern 1994). 2008 Feb 6;97(3):137-41. French. PMID: 18549014 [PubMed - indexed for MEDLINE]Related articles

Breast cancer: metastatic.

Johnston S, Stebbing J.

Clin Evid. 2002 Dec;(8):1785-810. Review. No abstract available. Update in: Clin Evid. 2003 Dec;(10):1975-2002. PMID: 12603970 [PubMed - indexed for MEDLINE]Related articles

The evolving role of oestrogen receptor beta in clinical breast cancer.

Speirs V.

Breast Cancer Res. 2008;10(5):111. Epub 2008 Sep 19.PMID: 18831727 [PubMed - indexed for MEDLINE]Related articlesFree article

Multitargeted therapy in estrogen receptor-positive, human epidermal growth factor receptor-2-positive breast cancer.

Nahleh ZA, Jazieh AR.

Am J Clin Oncol. 2005 Dec;28(6):631-3. No abstract available. PMID: 16317277 [PubMed - indexed for MEDLINE]Related articles

Influence of genistein and daidzein on Brca1 protein levels in human breast cell lines.

Bernard-Gallon DJ, Maurizis JC, Rio PG, Bignon YJ.

J Natl Cancer Inst. 1998 Jun 3;90(11):862-3. No abstract available. PMID: 9625177 [PubMed - indexed for MEDLINE]Related articles

Endocrine therapy of metastatic breast cancer.

Rodríguez Lajusticia L, Martín Jiménez M, López-Tarruella Cobo S.

Clin Transl Oncol. 2008 Aug;10(8):462-7. Review.PMID: 18667376 [PubMed - indexed for MEDLINE]Related articles

Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer.

Rexhepaj E, Brennan DJ, Holloway P, Kay EW, McCann AH, Landberg G, Duffy MJ, Jirstrom K, Gallagher WM.

Breast Cancer Res. 2008;10(5):R89. Epub 2008 Oct 23.PMID: 18947395 [PubMed - indexed for MEDLINE]Related articlesFree article

t(8;16) AML developed subsequent to breast cancer therapy.

Sahin FI, Yilmaz Z, Karakuş S, Boğa S, Akçali Z, DemIrhan B.

Hematology. 2006 Jun;11(3):153-5.PMID: 17326321 [PubMed - indexed for MEDLINE]Related articles

Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer.

Daskalaki A, Agelaki S, Perraki M, Apostolaki S, Xenidis N, Stathopoulos E, Kontopodis E, Hatzidaki D, Mavroudis D, Georgoulias V.

Br J Cancer. 2009 Aug 18;101(4):589-97. Epub 2009 Jul 21.PMID: 19623181 [PubMed - indexed for MEDLINE]Related articles

[Hormone-dependent, diploid, infiltrating ductal breast carcinomas less than 2 cm in size: influence of an exclusive and moderate cellular proliferation on the clinicobiological features and recurrences of these malignant tumors]

Ruibal A, Arias JI.

Rev Esp Med Nucl. 2002 Nov-Dec;21(6):437-8. Spanish. No abstract available. PMID: 12425893 [PubMed - indexed for MEDLINE]Related articles

Evolution of knowledge related to breast cancer heterogeneity: a 25-year retrospective.

Fisher B, Redmond CK, Fisher ER.

J Clin Oncol. 2008 May 1;26(13):2068-71. No abstract available. PMID: 18445835 [PubMed - indexed for MEDLINE]Related articles

Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer.

Klein CA, Blankenstein TJ, Schmidt-Kittler O, Petronio M, Polzer B, Stoecklein NH, Riethmüller G.

Lancet. 2002 Aug 31;360(9334):683-9.PMID: 12241875 [PubMed - indexed for MEDLINE]Related articles

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009.

Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Thürlimann B, Senn HJ; Panel members.

Ann Oncol. 2009 Aug;20(8):1319-29. Epub 2009 Jun 17.PMID: 19535820 [PubMed - indexed for MEDLINE]Related articlesFree article

Re: Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer.

Hrushesky WJ, Retsky M, Baum M, Demicheli R.

J Natl Cancer Inst. 2007 Jul 4;99(13):1053; author reply 1053-4. Epub 2007 Jun 27. No abstract available. PMID: 17596578 [PubMed - indexed for MEDLINE]Related articlesFree article